Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 7:13:998499.
doi: 10.3389/fendo.2022.998499. eCollection 2022.

Impact of admission and early persistent stress hyperglycaemia on clinical outcomes in acute pancreatitis

Affiliations

Impact of admission and early persistent stress hyperglycaemia on clinical outcomes in acute pancreatitis

Xinmin Yang et al. Front Endocrinol (Lausanne). .

Abstract

Background: To determine the impact of glucose levels at admission and during first week (early phase) on clinical outcomes in patients with acute pancreatitis (AP) and to investigate the relationship between stress hyperglycaemia (SHG) and hypertriglyceridaemia (HTG).

Methods: Two independent and prospective databases were retrospectively analysed (n = 1792). Patients admitted with pain of less than 48 hours and confirmed AP were included. SHG was defined as admission blood glucose ≥ 10.00 mmol/L (non-diabetic) or ≥ 16.67 mmol/L (diabetic). Blood glucose records for the first week were inspected to determine whether SHG lasted ≥ 48 hours (persistent) or < 48 hours (transient). Clinical outcomes were compared between designated patient groups using multivariate and trend analyses. The correlation between SHG and HTG (serum triglyceride ≥ 5.65 mmol/L) was also analysed.

Results: On admission, SHG was present in 27.8% (499/1792) patients; during the first 48 hours of admission, transient and persistent SHG was found in 31% (556/1792) and 8.0% (144/1792) patients, respectively. Admission SHG was associated with higher incidence of persistent organ failure, acute necrotic collection, major infection, and mortality as well as prolonged length of hospital stay (all P < 0.05). Duration of SHG was also associated with worsened clinical outcomes (all P < 0.05). In HTG-AP patients, more severe clinical outcomes were observed in those who concomitantly had SHG (P < 0.05).

Conclusions: Admission and persistent SHG during the first week of admission worsens clinical outcomes of AP patients. These effects are more pronounced when admission HTG co-existed.

Keywords: acute pancreatitis; blood glucose; clinical outcomes; hypertriglyceridaemia; stress hyperglycaemia.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Features of patients stratified by duration of stress hyperglycaemia during the first week of admission. (A) Severity classification. (B) Kaplan–Meier survival curve. (C) Survival curve after adjusting for age, gender, BMI, Charlson comorbidity index, time to admission, referral status, biliary aetiology and admission TG levels. SHG, stress hyperglycaemia; MAP, mild acute pancreatitis; MSAP, moderately severe acute pancreatitis; SAP, severe acute pancreatitis.
Figure 2
Figure 2
Trend analysis for clinical outcomes stratified by duration of stress hyperglycaemia. POF, persistent organ failure; MODS, Multiple Organ Dysfunction Syndrome; ANC, acute necrotic collection; LOHS, length of hospital stays.

Similar articles

Cited by

References

    1. Moggia E, Koti R, Belgaumkar AP, Fazio F, Pereira SP, Davidson BR, et al. . Pharmacological interventions for acute pancreatitis. Cochrane Database Syst Rev (2017) 4:CD011384. doi: 10.1002/14651858.CD011384.pub2 - DOI - PMC - PubMed
    1. Peery AF, Crockett SD, Murphy CC, Lund JL, Dellon ES, Williams JL, et al. . Burden and cost of gastrointestinal, liver, and pancreatic diseases in the united states: Update 2018. Gastroenterology (2019) 156(1):254–72 e11. doi: 10.1053/j.gastro.2018.08.063 - DOI - PMC - PubMed
    1. Cho J, Petrov MS. Pancreatitis, pancreatic cancer, and their metabolic sequelae: Projected burden to 2050. Clin Transl Gastroenterol (2020) 11(11):e00251. doi: 10.14309/ctg.0000000000000251 - DOI - PMC - PubMed
    1. Boxhoorn L, Voermans RP, Bouwense SA, Bruno MJ, Verdonk RC, Boermeester MA, et al. . Acute pancreatitis. Lancet (2020) 396(10252):726–34. doi: 10.1016/S0140-6736(20)31310-6 - DOI - PubMed
    1. Hines OJ, Pandol SJ. Management of severe acute pancreatitis. BMJ (2019) 367:l6227. doi: 10.1136/bmj.l6227 - DOI - PubMed

Publication types